Safety and Fidelity
Cross-source consensus on Safety and Fidelity from 1 sources and 5 claims.
1 sources · 5 claims
Risks & contraindications
Evidence quality
Other
Highlighted claims
- HDRS-24 ratings are performed by clinical raters blinded to treatment allocation. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Negative effects and psychotherapy side effects are measured at weeks 5, 10, 16, and 64. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Serious adverse events include death, life-threatening events such as suicide attempt, hospitalisation, and significant or permanent disability. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Therapist fidelity is supported through training, structured supervision, and expert-led workshops before recruitment. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial
- Patients and ward teams are kept unaware of the primary superiority hypothesis because psychotherapy assignment cannot be hidden from patients or therapists. — Efficacy, moderators and mediators of cognitive behavioural analysis system of psychotherapy (CBASP) versus behavioural activation (BA) in persistently depressed treatment-resistant inpatients: study protocol for the multicentre, randomised controlled changePDD trial